Chinese Journal of Antituberculosis ›› 2024, Vol. 46 ›› Issue (6): 707-712.doi: 10.19982/j.issn.1000-6621.20240034
• Original Articles • Previous Articles Next Articles
Lu Zenghui, Zhang Huijun(), Yue Xiaotong, Yan Jinyu
Received:
2024-01-22
Online:
2024-06-10
Published:
2024-06-03
Contact:
Zhang Huijun, Email: Supported by:
CLC Number:
Lu Zenghui, Zhang Huijun, Yue Xiaotong, Yan Jinyu. Clinical effect of one-stage posterior debridement,autogenous morselized bone graft and internal fixation in the treatment of thoracolumbar tuberculosis[J]. Chinese Journal of Antituberculosis, 2024, 46(6): 707-712. doi: 10.19982/j.issn.1000-6621.20240034
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20240034
[1] | 饶海涛, 董伟杰, 秦世炳. 653例胸椎结核临床特点分析. 中国防痨杂志, 2022, 44(7):675-680. doi:10.19982/j.issn.1000-6621.20220094. |
[2] | 鲁增辉, 罗卓荆, 段伟. 皮质骨轨迹螺钉内固定技术在单间隙腰椎结核治疗中的效果分析. 中国防痨杂志, 2018, 40(4):397-403. doi:10.3969/j.issn.1000-6621.2018.04.010. |
[3] | 唐恺, 董伟杰, 兰汀隆, 等. 一期后路病灶清除植骨内固定治疗上胸椎结核. 中国防痨杂志, 2014, 36(8):675-678. doi:10.3978/j.issn.2095-6959.2019.05.021. |
[4] | 张宏其. 如何全面认识和规范应用单纯经后路病灶清除椎体间植骨术治疗脊柱结核. 中国矫形外科杂志, 2018, 26(2):97-100. doi:10.3977/j.issn.1005-8478.2018.02.01. |
[5] | 王丛, 陈根元, 杨成业, 等. 改良后路病灶清除打压植骨内固定治疗胸腰椎结核. 中国脊柱脊髓杂志, 2011, 21(10):835-838. doi:10.3969/j.issn.1004-406X.2011.10.10. |
[6] | Xu Z, Wang X, Wu P, et al. Surgical treatment for mono-segmental lumbar tuberculosis by single-stage posterior debridement, compact bone grafting and posterior single-segment fixation. Injury, 2015, 46(7): 1311-1316. doi:10.1016/j.injury.2015.03.023. |
[7] | 崔旭, 马远征, 陈兴, 等. 脊柱结核前后路不同术式的选择及其疗效. 中国脊柱脊髓杂志, 2011, 21(10):807-812. doi:10.3969/j.issn.1004-406X.2011.10.05. |
[8] | 张会军, 鲁增辉, 杨全全, 等. 一期前路手术治疗胸椎结核伴食管裂孔疝1例. 中国防痨杂志, 2021, 43(6):642-644. doi:10.3969/j.issn.1000-6621.2021.06.021. |
[9] | 徐用亿, 季峰, 王守国, 等. 前路与后路术式治疗单节段腰椎结核的比较. 中国矫形外科杂志, 2018, 26(9):792-797. doi:10.3977/j.issn.1005-8478.2018.09.05. |
[10] | Wang LJ, Zhang HQ, Tang MX, et al. Comparison of three surgical approaches for thoracic spinal tuberculosis in adult. Spine (Phila Pa 1976), 2017, 42(11): 808-817. doi:10.1097/BRS.0000000000001955. |
[11] | 张宏其, 郭虎兵, 陈静, 等. 单纯后路病灶清除椎体间植骨融合内固定治疗脊柱结核的适应症及疗效评价. 中国矫形外科杂志, 2012, 20(3):196-199. doi:10.3977/j.issn.1005-8478.2012.03.02. |
[12] | 郭强, 张宏其. 单纯后路病灶清除椎体间植骨术治疗脊柱结核的研究进展. 中国矫形外科杂志, 2018, 26(2):150-154. doi:10.3977/j.issn.1005-8478.2018.02.11. |
[13] | Shi J, Tang X, Yong Q, et al. Single-stage internal fixation for thoracolumbar spinal tuberculosis using 4 different sugical approaches. J Spinal Disord Tech, 2014, 27(7):E247-257. doi:10.1097/BSD.0000000000000100. |
[14] | 官众, 许勇, 任磊, 等. 三种不同植骨方式在胸、腰椎结核手术治疗中的观察. 中国脊柱脊髓杂志, 2013, 23(6):488-492. doi:10.3969/j.issn.1004-406X.2013.06.02. |
[15] | Malham GM, Parker RM, Ellis NJ, et al. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of c ications. Neurosurg Spine, 2014, 21(6):851-860. doi:10.3171/2014.8.SPINE13524. |
[16] | 李卫平, 荀传辉, 盛伟斌, 等. 前路病灶清除植骨融合联合经皮椎弓根螺钉治疗胸腰椎结核. 实用骨科杂志, 2019, 25(5):442-445. doi:10.13795/j.cnki.sgkz.2019.05.014. |
[17] | 王丛, 陈根元, 杨成业, 等. 改良后路病灶清除打压植骨内固定治疗胸腰椎结核. 中国脊柱脊髓杂志, 2011, 21(10):835-838. doi:10.3969/j.issn.1004-406X.2011.10.10. |
[18] | Lu C, Li X, Zhang H, et al. Comparative effectiveness of two different interbody fusion methods for transforaminal lumbar interbody fusion:cage versus morselized impacted bone grafts. BMC Musculoskelet Disord, 2015, 16:207. doi:10.1186/s12891-0675-2. |
[19] | 唐庆才. 抗结核药物联合颗粒植骨与髂骨植骨融合术治疗单节段脊柱结核的疗效. 中国卫生标准管理, 2020, 11(24):75-78. doi:10.3969/j.issn.1674-9316.2020.24.028. |
[20] | 蒋官印, 欧云生, 朱勇, 等. 颗粒植骨,钛网植骨和髂骨植骨在后入路单节段腰椎结核病灶清除术中的疗效研究. 中国临床解剖学杂志, 2022, 40(2):204-210. doi:10.13418/j.issn.1001-165x.2022.2.16. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||